Literature DB >> 2875470

The neural substrates for the motor-activating properties of psychostimulants: a review of recent findings.

N R Swerdlow, F J Vaccarino, M Amalric, G F Koob.   

Abstract

Several different classes of pharmacological agents produce syndromes of behavioral activation in humans and infrahumans. While many of these agents, including direct and indirect sympathomimetics, methylxanthines, opiates and several neuropeptides have very distinct neurochemical profiles, it is not clear whether their behavioral stimulant action results from their action on a common neural substrate, or instead from their action on parallel but separate activation "circuits.' Using photocell measurements of motor activity in rats, it has been possible to demonstrate that some agents with very distinct neurochemical identities act on common neural substrates to produce behavioral activation, while other agents act on completely distinct brain regions. Specifically, the locomotor-activating properties of direct and indirect sympathomimetics and opiates appear to result from their action within the basal ganglia, including the ventral striatum and globus pallidus, while the activating properties of caffeine and the neuropeptide, corticotropin releasing factor (CRF) appear to be independent of this circuitry. These findings suggest the presence of at least two separate neural systems capable of mediating behavioral activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2875470     DOI: 10.1016/0091-3057(86)90261-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  34 in total

Review 1.  Protein kinase C isozymes and addiction.

Authors:  M Foster Olive; Robert O Messing
Journal:  Mol Neurobiol       Date:  2004-04       Impact factor: 5.590

2.  Differential regulation of motor control and response to dopaminergic drugs by D1R and D2R neurons in distinct dorsal striatum subregions.

Authors:  Pierre F Durieux; Serge N Schiffmann; Alban de Kerchove d'Exaerde
Journal:  EMBO J       Date:  2011-11-08       Impact factor: 11.598

3.  Expression of morphine-conditioned hyperactivity is attenuated by naloxone and pimozide.

Authors:  J L Neisewander; M T Bardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats.

Authors:  Khemraj Hirani; Ajay N Sharma; Nishant S Jain; Rajesh R Ugale; Chandrabhan T Chopde
Journal:  Psychopharmacology (Berl)       Date:  2005-02-18       Impact factor: 4.530

5.  A role for the mesolimbic dopamine system in the psychostimulant actions of MDMA.

Authors:  L H Gold; C B Hubner; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Sensitivity to self-administered cocaine within the lateral preoptic-rostral lateral hypothalamic continuum.

Authors:  David J Barker; Brendan M Striano; Kevin C Coffey; David H Root; Anthony P Pawlak; Olivia A Kim; Julianna Kulik; Anthony T Fabbricatore; Mark O West
Journal:  Brain Struct Funct       Date:  2014-03-07       Impact factor: 3.270

Review 7.  Pharmacological rationale for the clinical use of caffeine.

Authors:  J Sawynok
Journal:  Drugs       Date:  1995-01       Impact factor: 9.546

8.  Corticotropin releasing factor induces anxiogenic locomotion in trout and alters serotonergic and dopaminergic activity.

Authors:  Russ E Carpenter; Michael J Watt; Gina L Forster; Øyvind Øverli; Craig Bockholt; Kenneth J Renner; Cliff H Summers
Journal:  Horm Behav       Date:  2007-08-08       Impact factor: 3.587

9.  Effect of the mGluR5 antagonist 6-methyl-2-(phenylethynyl)pyridine (MPEP) on the acute locomotor stimulant properties of cocaine, D-amphetamine, and the dopamine reuptake inhibitor GBR12909 in mice.

Authors:  Andrew J Mcgeehan; Patricia H Janak; M Foster Olive
Journal:  Psychopharmacology (Berl)       Date:  2004-07       Impact factor: 4.530

10.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.